Low-threshold treatment programs

Seelos Therapeutics Announces the Selection of SLS-002 (intranasal racemic ketamine) for Inclusion in the U.S. Department of Defense's Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder (PTSD)

Retrieved on: 
Monday, November 27, 2023

NEW YORK, Nov. 27, 2023 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that SLS-002 (intranasal racemic ketamine) has been selected for inclusion in an adaptive platform trial to evaluate treatments for post-traumatic stress disorder (PTSD) in active-duty service members and veterans. The trial is funded by the U.S. Department of Defense's (DOD) Defense Health Agency and led by the Warfighter Readiness, Performance, and Brain Health Project Management Office, part of the U.S. Army Medical Materiel Development Activity.

Key Points: 
  • "We would like to thank the project managers and subcontractors to this study for their tireless effort in moving this program forward.
  • In addition, the trial will evaluate several biomarkers associated with PTSD and assessments of treatment safety and tolerability.
  • "This study provides an ideal opportunity to study SLS-002 for PTSD," said Tim Whitaker, M.D., Chief Medical Officer of Seelos.
  • "The current approved pharmacologic treatments for PTSD have a number of limitations, and there remains a high unmet medical need.

Suicide Prevention Advocates Seek Greater State Commitments to Improve Mental Health and Stop Suicide

Retrieved on: 
Tuesday, March 28, 2023

The goal of these conversations is to help lawmakers understand that investments in mental health and suicide prevention can and do save lives.

Key Points: 
  • The goal of these conversations is to help lawmakers understand that investments in mental health and suicide prevention can and do save lives.
  • Among adults with a diagnosed mental health condition, 43.8% did not receive mental health services in 2021.
  • AFSP advocates will raise awareness of the state actions, resources, and investments needed to support the thousands of [Insert State] residents affected by suicide and mental health conditions each year.
  • AFSP creates a culture that's smart about mental health through education and community programs, develops suicide prevention through research and advocacy, and provides support for those affected by suicide.

Infant with Rare Condition Receives Life-Saving At-Birth Procedure at Hassenfeld Children's Hospital at NYU Langone

Retrieved on: 
Thursday, September 22, 2022

NEW YORK, Sept. 21, 2022 /PRNewswire/ -- Aydin Idris Martin, an infant with an extremely rare and serious birth defect, was saved at birth when a multidisciplinary team at Hassenfeld Children's Hospital at NYU Langone performed a highly specialized procedure.

Key Points: 
  • The condition, the causes of which remain unknown, comes with a 100 percent mortality rate unless an intervention is performed.
  • The condition would make breathing impossible and fatal for the baby after a traditional delivery."
  • You need to have a medical center that offers all these subspecialists in one setting and that's Hassenfeld Children's Hospital at NYU Langone."
  • "The team at Hassenfeld Children's Hospital is now family to us," says Aydin's mother Yadi.

New opioid treatment option available for Tennessee residents

Retrieved on: 
Tuesday, April 26, 2022

Opioid addiction continues to ravage communities across the U.S., and in Tennessee, recent data tells us that the need for recovery services is pressing.

Key Points: 
  • Opioid addiction continues to ravage communities across the U.S., and in Tennessee, recent data tells us that the need for recovery services is pressing.
  • An estimated 50,000 Tennesseans aged 12 or older reported past year opioid use disorder, and 189,000 reported past year opioid misuse.
  • [i]
    119,000 Tennesseans aged 18 or older reported needing but not receiving treatment for illicit drug use in the past year.
  • Original Medicare, which all BHG centers accept, also fully covers OTP treatment with no out-of-pocket costs as of January 1, 2020.

Renowned Pediatric Surgeon Appointed Director of Children's Surgical Services at Hassenfeld Children's Hospital at NYU Langone

Retrieved on: 
Thursday, January 13, 2022

NEW YORK, Jan. 13, 2022 /PRNewswire/ -- Nationally renowned pediatric surgeon Jason C. Fisher, MD, has been named director of the Division of Pediatric Surgery , the William F. and Virginia Connolly Mitty Associate Professor of Pediatric Surgery at NYU Grossman School of Medicine, and director of Children's Surgical Services at Hassenfeld Children's Hospital at NYU Langone .

Key Points: 
  • NEW YORK, Jan. 13, 2022 /PRNewswire/ -- Nationally renowned pediatric surgeon Jason C. Fisher, MD, has been named director of the Division of Pediatric Surgery , the William F. and Virginia Connolly Mitty Associate Professor of Pediatric Surgery at NYU Grossman School of Medicine, and director of Children's Surgical Services at Hassenfeld Children's Hospital at NYU Langone .
  • In addition to his new positions, he will continue to serve as the surgical director of NYU Langone's Pediatric ECMO Program .
  • He will also continue to co-direct the Fetal Diagnosis and Treatment Program , in which pediatric, neonatal, and surgical subspecialists collaborate with maternalfetal medicine specialists to manage prenatal conditions.
  • An accomplished surgeon and leader, Fisher uses laparoscopic and minimally invasive surgical techniques, to address a wide range of surgical conditions in the chest and abdomen.

Blue Heron Neurofeedback and Counseling Announces New Employee & Expansion of Services to Littleton and Gorham, NH Offices

Retrieved on: 
Tuesday, September 21, 2021

GORHAM, N.H., Sept. 21, 2021 /PRNewswire/ -- Blue Heron Neurofeedback and Counseling is pleased to announce the official expansion of services and the opening of new offices in Gorham and Littleton.

Key Points: 
  • GORHAM, N.H., Sept. 21, 2021 /PRNewswire/ -- Blue Heron Neurofeedback and Counseling is pleased to announce the official expansion of services and the opening of new offices in Gorham and Littleton.
  • As part of the expansion, Blue Heron Neurofeedback and Counseling is now going to include Medical Assisted Treatment for substance use disorders, which complements their current array of existing counseling services.
  • The services Blue Heron provides include options such as mental health and substance use counseling with licensed clinicians, EMDR therapy, Neurofeedback, and Impaired Driver Care Management Program.
  • Blue Heron Neurofeedback and Counseling was founded by Stacie Leclerc MLADC, LCMHC.